regulatory
confidence high
sentiment negative
materiality 0.75
IO Biotech receives Nasdaq bid price deficiency notice; has until June 16, 2026 to regain compliance
IO Biotech, Inc.
- Nasdaq notified IO Biotech on Dec 17, 2025 that bid price < $1.00 for 30 consecutive days.
- Company has 180 calendar days, until June 16, 2026, to regain compliance.
- To comply, closing bid price must be >= $1.00 for at least 10 consecutive trading days.
- If not compliant by June 2026, may apply for a second 180-day period by transferring to Nasdaq Capital Market.
- No immediate effect on listing; stock continues trading on Nasdaq Global Select Market.